Literature DB >> 16412180

Low-dose dobutamine stress echocardiography to predict reversibility of mitral regurgitation with CABG.

Farideh Roshanali1, Mohammad Hossein Mandegar, Mohammad Ali Yousefnia, Farshid Alaeddini, Samuel Wann.   

Abstract

The optimal management of moderate (grade 2-3+) ischemic mitral regurgitation (MR) in patients undergoing coronary artery bypass grafting (CABG) remains controversial. While CABG alone can reverse regurgitation in some patients with moderate MR, adjunctive mitral repair may be necessary in others. We performed low-dose dobutamine stress echocardiography (DSE) in 60 patients with moderate MR who were about to undergo CABG. Group I, 25 patients who demonstrated reduction in MR during DSE, had CABG alone. Group II, 35 patients in whom MR was unchanged during DSE, had mitral valve repair as well as CABG. MR was reduced postoperatively in both groups (P < 0.0001). Postoperative ejection fraction in Group I (12.2%) improved more than that in Group II (9.3%) (P < 0.01). We conclude that CABG alone may be sufficient to correct moderate MR when MR is reduced during DSE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412180     DOI: 10.1111/j.1540-8175.2006.00163.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  4 in total

1.  Surgical treatment of moderate ischemic mitral regurgitation.

Authors:  Peter K Smith; John D Puskas; Deborah D Ascheim; Pierre Voisine; Annetine C Gelijns; Alan J Moskowitz; Judy W Hung; Michael K Parides; Gorav Ailawadi; Louis P Perrault; Michael A Acker; Michael Argenziano; Vinod Thourani; James S Gammie; Marissa A Miller; Pierre Pagé; Jessica R Overbey; Emilia Bagiella; François Dagenais; Eugene H Blackstone; Irving L Kron; Daniel J Goldstein; Eric A Rose; Ellen G Moquete; Neal Jeffries; Timothy J Gardner; Patrick T O'Gara; John H Alexander; Robert E Michler
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

2.  Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.

Authors:  Robert E Michler; Peter K Smith; Michael K Parides; Gorav Ailawadi; Vinod Thourani; Alan J Moskowitz; Michael A Acker; Judy W Hung; Helena L Chang; Louis P Perrault; A Marc Gillinov; Michael Argenziano; Emilia Bagiella; Jessica R Overbey; Ellen G Moquete; Lopa N Gupta; Marissa A Miller; Wendy C Taddei-Peters; Neal Jeffries; Richard D Weisel; Eric A Rose; James S Gammie; Joseph J DeRose; John D Puskas; François Dagenais; Sandra G Burks; Ismail El-Hamamsy; Carmelo A Milano; Pavan Atluri; Pierre Voisine; Patrick T O'Gara; Annetine C Gelijns
Journal:  N Engl J Med       Date:  2016-04-03       Impact factor: 91.245

3.  Wisdom of experience or faculty of reason: Ischemic mitral regurgitation trials-Cardiothoracic Surgical Trials Network and beyond.

Authors:  Robert E Michler
Journal:  JTCVS Open       Date:  2020-04-06

4.  Exploring the Operative Strategy for Secondary Mitral Regurgitation: A Systematic Review.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Francesca Bellomo; Pierluigi Nappi; Camilla Chello; Adelaide Iervolino; Massimo Chello
Journal:  Biomed Res Int       Date:  2021-06-22       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.